WebBETHESDA, Md., Jan. 12, 2024 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a biotechnology company transforming drug … WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. GAN Limited 50-day moving average is $1.71.
Should Biotechnology Stock Gain Therapeutics Inc (GANX) Be in …
WebStock Price Forecast The 4 analysts offering 12-month price forecasts for Gain Therapeutics Inc have a median target of 10.00, with a high estimate of 10.00 and a low estimate of 4.00. WebApr 11, 2024 · Their GAN share price forecasts range from $2.00 to $6.50. On average, they predict the company's share price to reach $3.50 in the next year. This suggests a possible upside of 171.3% from the stock's current price. View analysts price targets for GAN or view top-rated stocks among Wall Street analysts. heart shaped cookie cutter small
GAIN THERAPEUTICS (NASDAQ: GANX) STOCK QUOTE - Green Stock News
WebThe 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price … WebGANX: Get the latest Gain Therapeutics stock price and detailed information including GANX news, historical charts and realtime prices. WebMar 30, 2024 · Weaker technical forecast for Gain Therapeutics, Inc. as stock downgraded to Hold/Accumulate. (Updated on Mar 30, 2024) Buy or Hold candidate since 2024-03-13 Gain 14.04% PDF. The Gain Therapeutics, Inc. stock price fell by -2.28% on the last day (Thursday, 30th Mar 2024) from $4.82 to $4.71. During the last trading day the stock … mousehole archive group